NCT03923309

Brief Summary

Though refusal of radical surgery was often happened in rectal cancer patient after neoadjuvant chemoradiotherapy, little is currently known about the actual oncologic outcome of it. Thus the investigators designed this study to compare the oncologic outcome of unintended rectal preservation with intended rectal preservation by surgeon.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
142

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2016

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2016

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2017

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

April 16, 2019

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 22, 2019

Completed
Last Updated

April 22, 2019

Status Verified

April 1, 2019

Enrollment Period

1.7 years

First QC Date

April 16, 2019

Last Update Submit

April 19, 2019

Conditions

Keywords

Organ preservationOncologic outcome

Outcome Measures

Primary Outcomes (1)

  • 3-year overall survival

    Overall survival rate at 3-year after completion of chemoradiotherapy

    from date of completion of chemoradiotherapy until the date of death from any cause, whichever came first, assessed at 31th December 2017 by checking expire date of a resident registration number

Study Arms (2)

Intended rectal preservation

When rectal preservation (non-operative management or local excision) was agreed by their surgeon.

Unintended rectal preservation

When rectal preservation (non-operative management or local excision) was disagreed by their surgeon.

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Intended organ preservation * non-operative management or local excision selected by surgeon Unintended organ preservation * non-operative management or local excision persisted by patient and disagreed by surgeon

You may qualify if:

  • biopsy proven rectal cancer (anal verge ≤ 10cm)
  • neoadjuvant radiotherapy or chemoradiotherapy
  • no radical surgery after neoadjuvant therapy

You may not qualify if:

  • other malignant disease
  • other fatel disease
  • incompletion of half of radiotherapy course
  • metastasis on initial presentation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

National Cancer Center, Korea

Goyang-si, Gyeonggi-do, South Korea

Location

Seoul National University Bundang Hospital

Seongnam-si, Gyeonggi-do, 13620, South Korea

Location

Seoul National University Hospital

Seoul, South Korea

Location

Related Publications (3)

  • Ellis CT, Samuel CA, Stitzenberg KB. National Trends in Nonoperative Management of Rectal Adenocarcinoma. J Clin Oncol. 2016 May 10;34(14):1644-51. doi: 10.1200/JCO.2015.64.2066. Epub 2016 Mar 28.

    PMID: 27022115BACKGROUND
  • Cassidy RJ, Switchenko JM, Cheng E, Jiang R, Jhaveri J, Patel KR, Tanenbaum DG, Russell MC, Steuer CE, Gillespie TW, McDonald MW, Landry JC. Health care disparities among octogenarians and nonagenarians with stage II and III rectal cancer. Cancer. 2017 Nov 15;123(22):4325-4336. doi: 10.1002/cncr.30896. Epub 2017 Jul 31.

    PMID: 28759121BACKGROUND
  • Lee DY, Teng A, Pedersen RC, Tavangari FR, Attaluri V, McLemore EC, Stern SL, Bilchik AJ, Goldfarb MR. Racial and Socioeconomic Treatment Disparities in Adolescents and Young Adults with Stage II-III Rectal Cancer. Ann Surg Oncol. 2017 Feb;24(2):311-318. doi: 10.1245/s10434-016-5626-0. Epub 2016 Oct 20.

    PMID: 27766558BACKGROUND

MeSH Terms

Conditions

Rectal Neoplasms

Condition Hierarchy (Ancestors)

Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesIntestinal DiseasesRectal Diseases

Study Officials

  • Jae-Hwan Oh, Ph.D.

    National Cancer Center, Korea

    PRINCIPAL INVESTIGATOR
  • Kyu Joo Park, Ph.D.

    Seoul National University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Colorectal Surgeon, University Professor

Study Record Dates

First Submitted

April 16, 2019

First Posted

April 22, 2019

Study Start

May 1, 2016

Primary Completion

December 30, 2017

Study Completion

December 30, 2017

Last Updated

April 22, 2019

Record last verified: 2019-04

Data Sharing

IPD Sharing
Will not share

The row data generated during and/or analysed during the current study couldn't be shared to public or other researcher because of institutional policy.

Locations